Literature DB >> 24206429

A new era of podocyte-targeted therapy for proteinuric kidney disease.

Börje Haraldsson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24206429     DOI： 10.1056/NEJMe1312835

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease.

Authors:  Peter Mundel; Anna Greka
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

Review 2.  Podocytes and the quest for precision medicines for kidney diseases.

Authors:  Peter Mundel
Journal:  Pflugers Arch       Date:  2017-06-23       Impact factor: 3.657

3.  Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury.

Authors:  Ehtesham Arif; Ashish K Solanki; Pankaj Srivastava; Bushra Rahman; Wayne R Fitzgibbon; Peifeng Deng; Milos N Budisavljevic; Catalin F Baicu; Michael R Zile; Judit Megyesi; Michael G Janech; Sang-Ho Kwon; Justin Collier; Rick G Schnellmann; Deepak Nihalani
Journal:  Kidney Int       Date:  2019-05-06       Impact factor: 10.612

4.  Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?

Authors:  David J Salant
Journal:  J Am Soc Nephrol       Date:  2015-09-23       Impact factor: 10.121

Review 5.  β2-Adrenergic receptor agonism as a therapeutic strategy for kidney disease.

Authors:  Ali Kamiar; Keyvan Yousefi; Julian C Dunkley; Keith A Webster; Lina A Shehadeh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-02-10       Impact factor: 3.619

6.  Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis.

Authors:  Hannelore Sprenger-Mähr; Emanuel Zitt; Afschin Soleiman; Karl Lhotta
Journal:  Case Rep Transplant       Date:  2016-03-20

7.  DUSP6 protects murine podocytes from high glucose‑induced inflammation and apoptosis.

Authors:  Liqiang Chen; Yaokun Wang; Haiyan Luan; Guangyu Ma; Huiming Zhang; Guang Chen
Journal:  Mol Med Rep       Date:  2020-07-09       Impact factor: 2.952

8.  Mitoquinone Protects Podocytes from Angiotensin II-Induced Mitochondrial Dysfunction and Injury via the Keap1-Nrf2 Signaling Pathway.

Authors:  Zijing Zhu; Wei Liang; Zhaowei Chen; Jijia Hu; Jun Feng; Yun Cao; Yiqiong Ma; Guohua Ding
Journal:  Oxid Med Cell Longev       Date:  2021-08-13       Impact factor: 6.543
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.